Costs of adverse drug events in German hospitals--a microcosting study.

@article{Rottenkolber2012CostsOA,
  title={Costs of adverse drug events in German hospitals--a microcosting study.},
  author={Dominik Rottenkolber and J. Hasford and J{\"u}rgen Stausberg},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2012},
  volume={15 6},
  pages={868-75}
}
OBJECTIVE In Germany, only limited data are available to quantify the attributable resource utilization associated with adverse drug events (ADEs). The aim of this study was twofold: first, to calculate the direct treatment costs associated with ADEs leading to hospitalization and, second, to derive the excess costs and extra hospital days attributable to ADEs of inpatient treatments in selected German hospitals. METHODS This was a retrospective and medical record-based study performed from… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 67 references

Cost estimation methods in health economic evaluation]. Gesundheitsökonomie & Qualitätsmanagement 2010;15:251–9

  • C. Krauth
  • 2010
1 Excerpt

[ Cost of intensive care in a German hospital : costunit accounting based on the InEK matrix ]

  • J Martin, C Neurohr, M Bauer
  • Gesundheitsökonomie & Qualitätsmanagement
  • 2010

Similar Papers

Loading similar papers…